Callahan Advisors’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-31
| Closed | -$41K | – | 125 |
|
|
2019
Q4 | $41K | Hold |
31
| – | – | 0.01% | 133 |
|
|
2019
Q3 | $63K | Hold |
31
| – | – | 0.01% | 132 |
|
|
2019
Q2 | $71K | Hold |
31
| – | – | 0.01% | 135 |
|
|
2019
Q1 | $76K | Hold |
31
| – | – | 0.01% | 132 |
|
|
2018
Q4 | $37K | Hold |
31
| – | – | 0.01% | 129 |
|
|
2018
Q3 | $84K | Hold |
31
| – | – | 0.02% | 136 |
|
|
2018
Q2 | $84K | Hold |
31
| – | – | 0.02% | 125 |
|
|
2018
Q1 | $128K | Hold |
31
| – | – | 0.03% | 118 |
|
|
2017
Q4 | $79K | Hold |
31
| – | – | 0.02% | 123 |
|
|
2017
Q3 | $115K | Hold |
31
| – | – | 0.02% | 121 |
|
|
2017
Q2 | $128K | Hold |
31
| – | – | 0.03% | 120 |
|
|
2017
Q1 | $162K | Hold |
31
| – | – | 0.04% | 119 |
|
|
2016
Q4 | $160K | Buy |
+31
| New | +$160K | 0.04% | 111 |
|